Shares of Ardent Health Partners (ARDT) plummeted 5.22% in pre-market trading on Monday following a significant downgrade from KeyBanc Capital Markets. The healthcare company's stock faced pressure after analysts revised their outlook on the firm's performance.

KeyBanc downgraded Ardent Health from Overweight to Sector Weight, simultaneously removing its previous $20 price target. This adjustment comes in the wake of Ardent Health's recent third-quarter report, which appears to have raised concerns about the company's financial health. Analysts at KeyBanc specifically pointed to issues with Ardent's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) baseline, suggesting potential challenges in the company's core operational performance.

Despite the downgrade, it's worth noting that Ardent Health still maintains an average rating of Overweight from other analysts, with a mean price target of $14.77, according to FactSet data. However, today's sharp stock decline indicates that investors are taking the KeyBanc downgrade seriously, reassessing their positions in light of the new analysis. As the market digests this information, investors will be closely watching for any further updates or guidance from Ardent Health regarding its financial outlook and strategic plans to address the concerns raised by KeyBanc.